Search Within

Advanced Practice Providers

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Meeting Abstract (44)
  2. Journal Article (17)
  3. Research Letter (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (62)
  2. Sloan Kettering Institute Faculty (62)
  3. GSK Faculty (59)
  4. Nursing (58)
  5. Center for Hematologic Malignancies (46)
  6. Department of Medicine (44)

More Groups

People
  1. Michel Sadelain (32)
  2. Isabelle Riviere (31)
  3. Renier Brentjens (29)
  4. Elizabeth Halton (28)
  5. Jae Park (26)
  6. Xiuyan Wang (23)

More People

Years
  1. 2023 (2)
  2. 2022 (6)
  3. 2021 (6)
  4. 2020 (1)
  5. 2019 (10)
  6. 2018 (11)

More Years

Publications
  1. Journal of Clinical Oncology (15)
  2. Blood (13)
  3. Neuro-Oncology (5)
  4. Pediatric Blood and Cancer (5)
  5. Cancer Discovery (3)
  6. Cancer Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. American Society of Hematology (13)
  3. American Association for Cancer Research (7)
  4. Nature Publishing Group (5)
  5. Oxford University Press (5)
  6. Wiley Periodicals, Inc (5)

More Publishers

Results (62)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Sadelain, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Safe and effective re-induction of complete remissions in adults with relapsed B-ALL using 19-28z CAR CD19-targeted T cell therapy
    Meeting Abstract

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Taylor, C.; Wasielewska, T.; Qu, J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • A phase I study of the androgen signaling inhibitor ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Rathkopf, D. E.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Steinbrecher, J. E.; Arauz, G.; Curley, T.; Rix, P. J.; Maneval, E. C.; Chen, I.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase I/II safety and pharmacokinetic (PK) study of ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC): Phase I results of a Prostate Cancer Clinical Trials Consortium study
    Meeting Abstract

    Rathkopf, D. E.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Steinbrecher, J. E.; Arauz, G.; Rix, P. J.; Maneval, E. C.; Chen, I.; Fox, J. J.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody cixutumumab (cix) plus mTOR inhibitor temsirolimus (tem) in metastatic castration-resistant prostate cancer (mCRPC): Results of a phase I pilot study
    Meeting Abstract

    Rathkopf, D. E.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Borwick, L. S.; Momen, L.; Curley, T.; Arauz, G.; Larson, S. M.; Fleisher, M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Can PI3K/AKT pathway mutations predict for type of recurrence after conservative treatment for DCIS
    Meeting Abstract

    Sakr, R. A.; Andrade, V. P.; Muhsen, S.; Chandarlapaty, S.; Giri, D.; Olvera, N.; Paik, W.; Goldberg, J. I.; Van Zee, K. J.; Rosen, N.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
    Journal Article

    Brentjens, R. J.; Riviere, I.; Park, J. H.; Davila, M. L.; Wang, X.; Stefanski, J.; Taylor, C.; Yeh, R.; Bartido, S.; Borquez-Ojeda, O.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
    Journal Article

    Krug, L. M.; Dao, T.; Brown, A. B.; Maslak, P.; Travis, W.; Bekele, S.; Korontsvit, T.; Zakhaleva, V.; Wolchok, J.; Yuan, J.; more...
    Cancer Immunology, Immunotherapy (2010)

    Fulltext@MSK | Save
  • Pilot trial of a Wilms tumor-1 (WT1) peptide vaccine in patients with thoracic and myeloid neoplasms
    Meeting Abstract

    Brown, A. B.; Krug, L. M.; Maslak, P.; James, L. P.; Dao, T.; Tyson, L.; Chanel, S. M.; Bekele, S.; Scheinberg, D. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Palliative interventions in patients with symptomatic stage IV breast cancer
    Meeting Abstract

    Morrogh, M.; King, T. A.; Miner, T. J.; Fey, J.; Park, A.; Brennan, M. F.; Jacques, D. P.
    Irish Journal of Medical Science (2007)

    Fulltext@MSK | Save